{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T03:53:42Z","timestamp":1775620422941,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,10,15]],"date-time":"2010-10-15T00:00:00Z","timestamp":1287100800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s13277-010-0118-5","type":"journal-article","created":{"date-parts":[[2010,10,15]],"date-time":"2010-10-15T00:21:50Z","timestamp":1287102110000},"page":"265-271","source":"Crossref","is-referenced-by-count":36,"title":["Prognostic significance of HE4 expression in pulmonary adenocarcinoma"],"prefix":"10.1007","volume":"32","author":[{"given":"Shin-ichi","family":"Yamashita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keita","family":"Tokuishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Moroga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirei","family":"Kamei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiyo","family":"Miyawaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinsuke","family":"Takeno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Chujo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsunobu","family":"Kawahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,10,15]]},"reference":[{"key":"118_CR1","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1378\/chest.111.6.1710","volume":"111","author":"CF Mountain","year":"1997","unstructured":"Mountain CF. Revisions in the international system for staging lung cancer. Chest. 1997;111:1710\u20137.","journal-title":"Chest"},{"key":"118_CR2","unstructured":"Pass HI, Carbone DP, Johnson DH, Minna JD, ScagliottiGV, Turrisi III AT (2009) Principles and practice of lung cancer, 4th edn. Lippincott Williams & Wilkins, Philadelphia"},{"key":"118_CR3","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1038\/sj.onc.1205363","volume":"21","author":"L Bingle","year":"2002","unstructured":"Bingle L, Singleton V, Bingle CD. The putative ovarian tumour marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoforms. Oncogene. 2002;21:2768\u201373.","journal-title":"Oncogene"},{"key":"118_CR4","doi-asserted-by":"crossref","first-page":"14791","DOI":"10.1016\/S0021-9258(18)77182-2","volume":"265","author":"O Wiedow","year":"1990","unstructured":"Wiedow O, Schr\u00f6der JM, Gregory H, Young JA, Christophers E. Elafin: an elastase-specific inhibitor of human skin. Purification, characterization, and complete amino acid sequence. J Biol Chem. 1990;265:14791\u20135.","journal-title":"J Biol Chem"},{"key":"118_CR5","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.1073\/pnas.83.18.6692","volume":"83","author":"RC Thompson","year":"1986","unstructured":"Thompson RC, Ohlsson K. Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc Natl Acad Sci USA. 1986;83:6692\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"118_CR6","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0378-1119(99)00342-X","volume":"238","author":"M Schummer","year":"1999","unstructured":"Schummer M, Ng WV, Bumgarner RE, Nelson PS, Schummer B, Bednarski DW, et al. Comparative hybridization of an array of 21, 500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas. Gene. 1999;238:375\u201385.","journal-title":"Gene"},{"key":"118_CR7","first-page":"3695","volume":"63","author":"I Hellstr\u00f6m","year":"2003","unstructured":"Hellstr\u00f6m I, Raycraft J, Hayden-Ledbetter M, Ledbetter JA, Schummer M, McIntosh M, et al. The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma. Cancer Res. 2003;63:3695\u2013700.","journal-title":"Cancer Res"},{"issue":"5","key":"118_CR8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s13277-010-0049-1","volume":"31","author":"E Anastasi","year":"2010","unstructured":"Anastasi E, Granato T, Marchei GG, Viggiani V, Colaprisca B, Comploj S, et al. Ovarian tumor marker HE4 is differently expressed during the phases of the menstrual cycle in healthy young women. Tumour Biol. 2010;31(5):411\u20135.","journal-title":"Tumour Biol"},{"key":"118_CR9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s13277-009-0015-y","volume":"31","author":"E Anastasi","year":"2010","unstructured":"Anastasi E, Marchei GG, Viggiani V, Gennarini G, Frati L, Reale MG. HE4: a new potential early biomarker for the recurrence of ovarian cancer. Tumour Biol. 2010;31:113\u20139.","journal-title":"Tumour Biol"},{"key":"118_CR10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.canlet.2010.03.013","volume":"296","author":"I Hellstrom","year":"2010","unstructured":"Hellstrom I, Heagerty PJ, Swisher EM, Liu P, Jaffar J, Agnew K, et al. Detection of the HE4 protein in urine as a biomarker for ovarian neoplasms. Cancer Lett. 2010;296:43\u20138.","journal-title":"Cancer Lett"},{"key":"118_CR11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1465-9921-7-61","volume":"7","author":"L Bingle","year":"2006","unstructured":"Bingle L, Cross SS, High AS, Wallace WA, Rassl D, Yuan G, et al. WFDC2 (HE4): a potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung. Respir Res. 2006;7:61\u201370.","journal-title":"Respir Res"},{"key":"118_CR12","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/modpathol.3800612","volume":"19","author":"MT Galgano","year":"2006","unstructured":"Galgano MT, Hampton GM, Frierson Jr HF. Comprehensive analysis of HE4 expression in normal and malignant human tissues. Mod Pathol. 2006;19:847\u201353.","journal-title":"Mod Pathol"},{"key":"118_CR13","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-04-3924","volume":"65","author":"R Drapkin","year":"2005","unstructured":"Drapkin R, von Horsten HH, Lin Y, Mok SC, Crum CP, Welch WR, et al. Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas. Cancer Res. 2005;65:2162\u20139.","journal-title":"Cancer Res"},{"key":"118_CR14","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1158\/1078-0432.CCR-05-2007","volume":"12","author":"N Scholler","year":"2006","unstructured":"Scholler N, Crawford M, Sato A, Drescher CW, O\u2019Briant KC, Kiviat N, et al. Bead-based ELISA for validation of ovarian cancer early detection markers. Clin Cancer Res. 2006;12:2117\u201324.","journal-title":"Clin Cancer Res"},{"key":"118_CR15","doi-asserted-by":"crossref","first-page":"13784","DOI":"10.1073\/pnas.241500798","volume":"98","author":"ME Garber","year":"2001","unstructured":"Garber ME, Troyanskaya OG, Schluens K, Petersen S, Thaesler Z, Pacyna-Gengelbach M, et al. Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci USA. 2001;98:13784\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"118_CR16","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1200\/JCO.2004.04.109","volume":"22","author":"H Endoh","year":"2004","unstructured":"Endoh H, Tomida S, Yatabe Y, Konishi H, Osada H, Tajima K, et al. Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reaction. J Clin Oncol. 2004;22:811\u20139.","journal-title":"J Clin Oncol"},{"key":"118_CR17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1470-2045(06)70579-4","volume":"7","author":"D Bouchard","year":"2006","unstructured":"Bouchard D, Morisset D, Bourbonnais Y, Tremblay GM. Proteins with whey-acidic-protein motifs and cancer. Lancet Oncol. 2006;7:167\u201374.","journal-title":"Lancet Oncol"},{"key":"118_CR18","doi-asserted-by":"crossref","first-page":"5778","DOI":"10.1073\/pnas.1037154100","volume":"100","author":"N Devoogdt","year":"2003","unstructured":"Devoogdt N, Hassanzadeh Ghassabeh G, Zhang J, Brys L, De Baetselier P, Revets H. Secretory leukocyte protease inhibitor promotes the tumorigenic and metastatic potential of cancer cells. Proc Natl Acad Sci U S Am. 2003;100:5778\u201382.","journal-title":"Proc Natl Acad Sci U S Am"},{"key":"118_CR19","first-page":"819","volume":"62","author":"B Ryu","year":"2002","unstructured":"Ryu B, Jones J, Blades NJ, Parmigiani G, Hollingsworth MA, Hruban RH, et al. Relationships and differentially expressed genes among pancreatic cancers examined by large-scale serial analysis of gene expression. Cancer Res. 2002;62:819\u201326.","journal-title":"Cancer Res"},{"key":"118_CR20","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.canlet.2006.01.020","volume":"245","author":"H Zhu","year":"2007","unstructured":"Zhu H, Lam DC, Han KC, Tin VP, Suen WS, Wang E, et al. High resolution analysis of genomic aberrations by metaphase and array comparative genomic hybridization identifies candidate tumour genes in lung cancer cell lines. Cancer Lett. 2007;245:303\u201314.","journal-title":"Cancer Lett"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-010-0118-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-010-0118-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-010-0118-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T22:32:27Z","timestamp":1636669947000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-010-0118-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,15]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["118"],"URL":"https:\/\/doi.org\/10.1007\/s13277-010-0118-5","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,15]]}}}